Hormone Therapy Market, By Therapy Type (Estrogen Therapy, Progesterone Therapy, Combination Therapy (Estrogen + Progesterone), Testosterone Therapy, Thyroid Hormone Therapy, Growth Hormone Therapy, Insulin Therapy, and Others (e.g., Corticosteroids, Parathyroid Hormones)), By Product Formulation (Tablets and Capsules (e.g., Oral Estrogen, Thyroid Hormones), Patches (e.g., Transdermal Estradiol), Gels and Creams (e.g., Testosterone Gels, Estradiol Gels), Injections (e.g., Depot Formulations), Implants and Pellets (e.g., Subcutaneous Hormone Implants), and Sprays (e.g., Nasal Testosterone)), By Application (Menopause Management, Osteoporosis, Hypothyroidism and Hyperthyroidism, Growth Hormone Deficiency, Hypogonadism, Cancer (Breast, Prostate, Others), Diabetes Management (Insulin Therapy), and Others (Infertility, Gender Affirmation, Adrenal Disorders)), By Route of Administration (Oral, Parenteral, Transdermal, Intranasal, Sublingual, and Other Routes (e.g., Vaginal Rings)), By Gender (Female and Male), By Age Group (Adult, Pediatric, and Geriatric), By End User (Hospitals, Specialty Clinics, Homecare Settings, and Research and Academic Institutes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)